BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11050841)

  • 1. [Thyroid lymphoma. A case report].
    Pérez JA; Ramírez R; Carpio D; Carrasco C; Pérez A
    Rev Med Chil; 2000 Jul; 128(7):783-6. PubMed ID: 11050841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thyroid lymphoma in a 51-year-old woman].
    Herranz MT; Corrales A; Molina MA; Redondo E; Almagro M; Martí J
    An Med Interna; 1993 Mar; 10(3):132-4. PubMed ID: 7683502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary lymphoma of the thyroid: a case report].
    Dem A; Traore B; Diallo BK; Mbodj M; Dieng MM; Kasse AA; Dangou JM; Diouf R; Toure P
    Dakar Med; 2004; 49(1):10-2. PubMed ID: 15782469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
    Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
    J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    Noordijk EM; Carde P; Dupouy N; Hagenbeek A; Krol AD; Kluin-Nelemans JC; Tirelli U; Monconduit M; Thomas J; Eghbali H; Aleman BM; Bosq J; Vovk M; Verschueren TA; Pény AM; Girinsky T; Raemaekers JM; Henry-Amar M
    J Clin Oncol; 2006 Jul; 24(19):3128-35. PubMed ID: 16754934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paucity of hematological neoplasia after treatment of Hodgkin disease: observation after long-term follow-up at Cancer Institute, Chennai, south India.
    Sagar TG; Chandra A; Raman SG; Swaminathan R
    Pediatr Hematol Oncol; 2002; 19(3):197-203. PubMed ID: 11936733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary non-Hodgkin's lymphoma of the thyroid. A case report and review of the literature].
    Belcadhi M; el Omri H; Gnaba K; Mani R; Abdelkefi M; Bouzouita K; Ennabli S; Bouzouita H
    Tunis Med; 2003 Feb; 81(2):130-3. PubMed ID: 12708180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relapse of Hodgkin disease after 17 years of complete remission. A case report].
    Osorio G; Caglevic C
    Rev Med Chil; 2003 Feb; 131(2):197-9. PubMed ID: 12708259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A pregnant woman with autoimmune thyroiditis and recurrent goiter].
    Santoe MF; Van Houten AA; Muller AF; Berghout A
    Ned Tijdschr Geneeskd; 2004 Jul; 148(29):1455-9. PubMed ID: 15326651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
    J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
    Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
    Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Composite lymphoma consisting of Hodgkin lymphoma and follicular lymphoma].
    Uchida T; Sugimoto K; Koike M
    Rinsho Ketsueki; 2009 Feb; 50(2):83-6. PubMed ID: 19265299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrences in lymphogranulomatosis].
    Kovalenko NS; Fokina NT
    Ter Arkh; 1983; 55(8):43-8. PubMed ID: 6688890
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
    Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML
    J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Various disputable problems of ambulatory treatment of tumors of the blood system].
    Vorob'ev AI; Brilliant MD
    Ter Arkh; 1984; 56(1):18-24. PubMed ID: 6546813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.